Podcasts about Efficacy

We have the privilege to discuss 95 Theses on the Reformation of Football: Disputation on the Power and Efficacy of Global Football Governance with author, Dr David Kilpatrick. Over two parts we discuss the state of the sport, how we've come to adore it, and how to best preserve association football, or soccer. World Cups, Promotion & Relegation, Closed Systems, and Women's access to the sport are all covered. It's a long listen, but incredibly informative and full of ideas and opinions which might engage your intellectual mode.

In this episode of the Longevity Optimization Podcast, Dr. Carolina Reis Oliveira, co-founder and CEO of OneSkin, shares her journey in stem cell biology and the development of innovative products focused on skin and hair health. With a PhD in immunology and a background in stem cell and tissue engineering, Dr. Carolina leads OneSkin's research and development efforts to create molecules that target cellular aging, including the groundbreaking OS-01 peptide.OneSkin is a biotechnology company founded in 2016 and based in Silicon Valley, focused on developing anti-aging skin and hair products. Under Dr. Carolina Reis Oliveira's leadership, OneSkin aims to delay the onset of age-related diseases by targeting cellular aging mechanisms. Their flagship innovation, the OS-01 peptide, is scientifically designed to reduce senescent cells, promoting skin and hair health at a molecular level. The company combines cutting-edge research with practical applications to create products that support longevity and wellness.Save On OneSkin Hair Here: oneskin.co/KAYLALet's be friends!Instagram: https://www.instagram.com/kaylabarnes/?hl=enTikTok: https://www.tiktok.com/@femalelongevityX: https://x.com/femalelongevityWebsite: https://kaylabarnes.comJoin Female Longevity Community: https://kayla-barnes-lentz.circle.so/checkout/become-a-memberFollow One Skin:Instagram: https://www.instagram.com/oneskin.co/?hl=enTikTok: https://www.tiktok.com/@oneskin.coTimestamps00:00 Introduction to Longevity and Skin Health02:50 Understanding Hair Biology and Growth Phases07:00 Root Causes of Hair Loss10:10 Addressing Hair Loss: Diagnosis and Treatments12:03 Current Hair Loss Products and Their Limitations17:12 Innovative Solutions: OS1 Hair Product Development20:51 Clinical Study Results and Efficacy of Hair Treatments24:22 Combining Therapies for Optimal Hair Health25:03 Scalp Care and Hair Washing Practices28:24 Understanding Scalp Health and Microbiome33:55 Preventative Measures for Hair Loss39:57 Innovative Approaches to Hair Thinning46:18 The Science Behind Peptides and Hair Care

Contributor: Aaron Lessen, MD Educational Pearls: How do we take care of kids in severe pain? There are many non-pharmacologic options for pain (i.e. ice, elevation) as well as more conventional medication options (i.e. acetaminophen, NSAIDS) but in severe pain stronger medications might be indicated. These stronger medications include options such as IV morphine, a subdissociative dose of ketamine, as well as intranasal fentanyl. Intranasal fentanyl has many advantages: Studies have shown it might be more effective early on in controlling pain, as in the first 15-20 minutes after administration, and then becomes equivalent to other pain control options Total adverse effects were also lower with IN fentanyl, including low rates of nausea and vomiting To administer, use the IV formulation with an atomizer and spray into the nose; therefore, you do not need an IV line Dose is 1-2 micrograms per kilogram, can be redosed once at 10 minutes.  Don't forget about gabapentinoids for neuropathic pain, muscle relaxants for muscle spasms, and nerve blocks when appropriate. (Disclaimer: muscle relaxers have not been well studied in children) References Alsabri M, Hafez AH, Singer E, Elhady MM, Waqar M, Gill P. Efficacy and Safety of Intranasal Fentanyl in Pediatric Emergencies: A Systematic Review and Meta-analysis. Pediatr Emerg Care. 2024 Oct 1;40(10):748-752. doi: 10.1097/PEC.0000000000003187. Epub 2024 Apr 11. PMID: 38713846. Bailey B, Trottier ED. Managing Pediatric Pain in the Emergency Department. Paediatr Drugs. 2016 Aug;18(4):287-301. doi: 10.1007/s40272-016-0181-5. PMID: 27260499. Hadland SE, Agarwal R, Raman SR, Smith MJ, Bryl A, Michel J, Kelley-Quon LI, Raval MV, Renny MH, Larson-Steckler B, Wexelblatt S, Wilder RT, Flinn SK. Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline. Pediatrics. 2024 Sep 30:e2024068752. doi: 10.1542/peds.2024-068752. Epub ahead of print. PMID: 39344439. Summarized by Jeffrey Olson, MS4 | Edited by Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

We have the privilege to discuss 95 Theses on the Reformation of Football: Disputation on the Power and Efficacy of Global Football Governance with author, Dr David Kilpatrick. Over two parts we discuss the state of the sport, how we've come to adore it, and how to best preserve association football, or soccer. World Cups, Promotion & Relegation, Closed Systems, and Women's access to the sport are all covered. It's a long listen, but incredibly informative and full of ideas and opinions which might engage your intellectual mode.

This week, Kate, Mark, Gary and Henry discuss 4 great new POEMs: foot care wipes for patients at risk of diabetic foot infection, resuming DOACS following intracerebral hemorrhage in adults with a fib, treating prediabetes with tirzepatide, and more on intermittent fasting.Show linksBMJ Magic Evidence interactive review of diabetes medications. A great practice and teaching tool: https://matchit.magicevidence.org/230125dist-diabetes/#!/https://www.ncbi.nlm.nih.gov/pubmed/31574019https://pubmed.ncbi.nlm.nih.gov/39964684/ https://pubmed.ncbi.nlm.nih.gov/40023176/ttps://pubmed.ncbi.nlm.nih.gov/39536238/https://pubmed.ncbi.nlm.nih.gov/40163873/

Acesse o Guia de bolso de IOT do TdC no link: http://bit.ly/4dyi6n8Pedro Magno e Lucca Cirillo conversam sobre os alvos de LDL em 4 populações:- Evento cardiovascular prévio- Presença de diabetes- LDL > 190 mg/dL- Outras situações Veja mais em https://www.tadeclinicagem.com.br/guia/259/hipercolesterolemia-familiar/Veja o vale a pena ouvir de novo em https://www.youtube.com/watch?v=k42rmssU1xE&ab_channel=TadeClinicagemReferências:1. Mach, François et al. “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.” European heart journal vol. 41,1 (2020): 111-188. doi:10.1093/eurheartj/ehz4552. Faludi, André Arpad et al. “Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017.” Arquivos brasileiros de cardiologia vol. 109,2 Supl 1 (2017): 1-76. doi:10.5935/abc.201701213. Grundy, Scott M et al. “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” Journal of the American College of Cardiology vol. 73,24 (2019): 3168-3209. doi:10.1016/j.jacc.2018.11.0024. Pearson, Glen J et al. “2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.” The Canadian journal of cardiology vol. 37,8 (2021): 1129-1150. doi:10.1016/j.cjca.2021.03.0165. Marx, Nikolaus et al. “2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.” European heart journal vol. 44,39 (2023): 4043-4140. doi:10.1093/eurheartj/ehad1926. Vrints, Christiaan et al. “2024 ESC Guidelines for the management of chronic coronary syndromes.” European heart journal vol. 45,36 (2024): 3415-3537. doi:10.1093/eurheartj/ehae1777. Hong, Sung-Jin et al. “Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.” JAMA vol. 329,13 (2023): 1078-1087. doi:10.1001/jama.2023.24878. Cannon, Christopher P et al. “Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.” The New England journal of medicine vol. 372,25 (2015): 2387-97. doi:10.1056/NEJMoa14104899. Sabatine, Marc S et al. “Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.” The New England journal of medicine vol. 376,18 (2017): 1713-1722. doi:10.1056/NEJMoa161566410. http://departamentos.cardiol.br/sbc-da/2015/calculadoraer2017/etapa1.html11. Lipidology update: targets and timing of well-established therapies, Luigina Guasti 1, MD, PhD, FAHA, FESC; Alessandro Lupi 2, MD at https://www.escardio.org/Councils/Council-for-Cardiology-Practice-(CCP)/Cardiopractice/lipidology-update-targets-and-timing-of-well-established-therapies12. Ray, Kausik K et al. “EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.” European journal of preventive cardiology vol. 28,11 (2021): 1279-1289. doi:10.1093/eurjpc/zwaa04713. Cholesterol Treatment Trialists' (CTT) Collaboration et al. “Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.” Lancet (London, England) vol. 376,9753 (2010): 1670-81. doi:10.1016/S0140-6736(10)61350-5

What if the very tools we rely on to detect breast cancer were putting us at risk? In this eye-opening episode, I sit down with Dr. John Klock, a visionary physician and medical imaging innovator, to expose the truth behind traditional screening methods and reveal a safer, more effective alternative: QT Ultrasound.Dr. Klock shares his incredible journey—from personal diagnosis to pioneering a breakthrough technology that's transforming breast imaging. Together, they unpack the challenges of disrupting an entrenched system, the common misconceptions around FDA clearance vs. approval, and the critical role of metabolic health in breast cancer risk.This episode is packed with life-changing insights about QT technology, the future of screening, and why informed decision-making is every woman's right. If you've ever questioned the safety or necessity of mammography, this conversation is a must-listen.Dr. John Klock is a physician, scientist, and the founder of QT Imaging. With a decades-long career in medical innovation, Dr. Klock is leading the charge to bring safer, radiation-free, high-resolution breast imaging to women across the world. His mission: to change the standard of care in breast health. In This Episode, You Will Learn:Why current imaging methods may be doing more harm than goodHow QT Ultrasound works—and why it's a game changerWhat it means that mammography was never formally FDA-clearedWhy metabolic health is at the center of breast cancer preventionWho qualifies for QT Imaging and how often you actually need to screen✨ This episode is an invitation to reclaim your health with confidence and clarity.If this episode resonated with you, please follow, rate, and leave a review on your favorite podcast platform. And most importantly—share it with a woman you love. This information could change, or even save, her life.

In this episode of Quah (Q & A), Sal, Adam & Justin answer four Pump Head questions drawn from last Sunday's Quah post on the @mindpumpmedia Instagram page.  Mind Pump Fit Tip: The 5 best diets for ANY goal. (1:38) The MOST common mistake people make with fitness & diet. (19:53) The BEST recovery tool to manage stress. (31:03) Terrible/harming tactics by mainstream media. (35:27) Creatine and depression. (41:27) The history of ginseng. (44:12) The conspiracy theory behind art. (48:36) Kids say the darndest things. (53:12) Mind Pump Recommends You Can't Ask That on Netflix. (56:21) Train the Trainer 3-Part Bonus Series dropping May 19th! (1:00:47) #Quah question #1 – What do you guys do to keep up strength when resting an injury? (1:01:37) #Quah question #2 – What should you do if you are reverse dieting but see weight gain? (1:04:17) #Quah question #3 – Will taking NSAID's to treat an acute injury completely negate gains from strength training? (1:06:04) #Quah question #4 – How do you see AI affecting the fitness industry? What are the pros and cons that can come of its involvement for trainers, nutrition coaches and their clients? (1:09:26) Related Links/Products Mentioned Visit Eight Sleep for an exclusive offer for Mind Pump Listeners! ** Use the code MINDPUMP to get $350 off your very own Pod 5 Ultra. The best part is that you still get 30 days to try it at home and return it if you don't like it - - Shipping to many countries worldwide. ** Visit Joy Mode for an exclusive offer for Mind Pump listeners! ** Enter MINDPUMP at checkout for 20% off your first order. ** May Special: MAPS 15 Performance or RGB Bundle 50% off! ** Code MAY50 at checkout ** Labs - Stephen Cabral Why Are Americans So Obsessed With Protein? Blame MAGA Creatine Supplementation in Depression: A Review of Mechanisms, Efficacy, Clinical Outcomes, and Future Directions Mind Pump #2530: Why All Women Should Take Creatine The history of ginseng in the management of erectile dysfunction in ancient China (3500-2600 BCE) Watch You Can't Ask That - Netflix Train the Trainer Webinar Series – 3 Part Bonus Series  Visit Hiya for an exclusive offer for Mind Pump listeners! ** Receive 50% off your first order ** Mechanisms and applications of the anti-inflammatory effects of photobiomodulation Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Mikhaila Peterson (@mikhailapeterson) Instagram Dr. Stephen Cabral (@stephencabral) Instagram Benjamin Bikman (@benbikmanphd) Instagram  

Safety And Efficacy Of The Unilateral, Suture-based, Dry-closure Technique In Percutaneous Trans-axillary Aortic Valve Implantation

On this special Ask the Authors episode, Drs. David Doubblestein and Linda Koehler join us to discuss the non-manual lymphatic drainage narrative, why it's never been about the volume, and the evidence supporting MLD as a critical component of complete decongestive therapy for lymphedema. Don't throw MLD out with the volume!

Tirzepatide is more effective for weight loss than semaglutide.Cost-effectiveness is crucial in prescribing weight loss medications.Patients with severe obesity should receive more expensive medications for better outcomes.Both medications show significant benefits for obesity-related conditions.Long-term studies indicate sustained weight loss with both drugs.Gender differences affect weight loss outcomes with these medications.Safety profiles show tirzepatide may be better tolerated than semaglutide.The need for affordable drug pricing is emphasized.Clinical benefits extend beyond weight loss to include metabolic health.Future studies are needed to confirm cardiovascular benefits of tirzepatide.Click here to see the studyClick here to join Dr. Spencer's new online clinic

In today's VETgirl online veterinary continuing education podcast, we review the American Heartworm Society (AHS) heartworm treatment protocol used in dogs in a recent study by Romito et al. entitled “Efficacy and tolerability of the American Heartworm Society therapeutic protocol in dogs affected by heartworm disease without caval syndrome.” Heartworm, Dirofilaria immitis, is one of the most common and important parasites in dogs, but also affects cats, as well as a myriad of other animals, including ferrets. This disease is totally preventable with the regular administration of macrocyclic lactone drugs; however, not every animal gets these preventives.

This episode delves into one of the most pertinent topics for today's practitioners—the efficacy and safety of spinal adjustments for managing acute neck pain—based on a newly published systematic review and meta-analysis in 2025. This research strongly supports the use of spinal adjustments as a first-line treatment for acute neck pain, providing both pain relief and restored function safely and effectively. Plus, that's a compelling message to share with your patients on social and in your local healthcare networks.Episode Notes: Efficacy and safety of spinal manipulative therapy in the management of acute neck pain: a systematic review and meta-analysisThe Best Objective Assessment of the Cervical Spine- Provide reliable assessments and exercises for Neuromuscular Control, Proprioception, Range of Motion, and Sensorimotor-Integration. Learn more at NeckCare.comTurncloud EHR- Minimalist design, without being sparse. Practical, yet elegant. Turncloud's design was to find the most efficient path in a day in the life of a chiropractic office. Connect with their team at www.turncloud.com Patient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056 Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289) Speakers: Brad Rovin, MD Richard Furie, MD Jack Cush, MD

Osteoporosis silently compromises bone strength, leading to increased fracture risk, especially in women over 50. In this comprehensive video, we delve into natural and science-backed strategies to enhance bone density and combat osteoporosis. Topics Covered: Exercise & Mechanical Loading: Importance of weight-bearing and resistance exercises. Insights into OsteoStrong® sessions and their impact on bone mineral density.  Overview of the OsteoBoost® belt and its FDA clearance.  Advanced Therapies: Benefits of Hyperbaric Oxygen Therapy (HBOT) in bone healing.  Role of Red/Near-Infrared Light Therapy in bone regeneration.  Discussion on peptide therapies like Teriparatide and Ibutamoren. Nutrition & Supplementation: Efficacy of AlgaeCal® in improving bone mineral density.  Synergistic effects of Vitamin D3 and K2 on bone health.  Benefits of collagen peptides and tocotrienol-rich Vitamin E.  Hormonal Health: Impact of estrogen, progesterone, testosterone, and DHEA on bone density.  Considerations for hormone replacement therapy. Medications & Monitoring: Risks associated with bisphosphonates and long-term use. Importance of DEXA scans in monitoring bone health. Effects of steroid medications on bone strength.  Featured Expert: Dr. Doug Lucas, a renowned orthopedic surgeon, shares his insights on optimising bone health through a holistic approach. Learn more about his work at drdouglucas.com. Related Podcast: For an in-depth discussion on osteoporosis and bone health, watch the following podcast: YouTube Video Empower yourself with knowledge and take proactive steps towards stronger bones and a healthier future. References: Mortality and cause of death in hip fracture patients aged 65 or older.  Effective Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Women.  Wearable vibration device - FDA clearance for OsteoBoost Belt.  Hyperbaric oxygen therapy for promoting fracture healing.  NIR light-assisted phototherapies for bone-related diseases.  Effect of Teriparatide on Bone Mineral Density and Bone Markers.  Treatment with the oral growth hormone secretagogue MK-677.  A 7-Year Longitudinal Trial of the Safety and Efficacy of AlgaeCal.  Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density.  Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers.  Tocotrienol supplementation in postmenopausal osteoporosis.  A systematic review and meta-analysis of DHEA supplementation on bone mineral density.  Glucocorticoid-Induced Osteoporosis Clinical Practice Guidelines.  

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Michael Mina to explore the nuanced realities of COVID-19 vaccines and public health communication. The scientists examine the limitations of current vaccines in preventing transmission and how this has affected public trust. Dr. Mina introduces the critical concept of immune amnesia, particularly in relation to measles, explaining its profound implications for understanding immunity. The conversation places current vaccine challenges in historical context while discussing the ongoing pursuit of universal vaccines. Throughout the episode, the experts emphasize the importance of transparent, accurate scientific communication in building and maintaining public trust in vaccination programs. (00:00) Intro (04:34) The Role of COVID-19 Vaccines in Transmission (11:55) Understanding Vaccine Efficacy and Mistrust (18:11) Comparing Vaccines: COVID-19 vs. Measles (18:30) The Future of Vaccines: Universal Protection (23:21) Communication Challenges in Public Health Messaging (25:07) Navigating Scientific Terminology and Public Perception (28:11) Understanding Measles: Historical Context and Public Misconceptions (32:24) The Efficacy of the MMR Vaccine: New Insights (38:11) Immune Amnesia: The Hidden Dangers of Measles (48:18) Conclusion: The Importance of Vaccination and Public Health Awareness https://www.harvardmagazine.com/2025/03/measles-immune-amnesia https://www-webflow.emed.com/team-member/michael-mina https://www.prnewswire.com/news-releases/c2sense-welcomes-dr-michael-mina-md-phd-chief-scientific-officer-of-emed-digital-healthcare-to-board-of-directors-302156846.html ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices

  Dr. Nicole Stevens, Vice President of Clinical Research at Doterra, discussed the latest findings from Doterra's science team, emphasizing the effectiveness of essential oils combined with high-quality supplementation for wellness. She also shared challenges in researching doTERRA products, the development and benefits of several supplements, and the research and effects of On Guard products. Lastly, she shared her personal story about her husband's sudden paralysis and the potential of DDR Prime essential oil blend, and discussed the importance of not overwhelming the body with too many supplements at once. Doterra's Science Team Discusses Wellness Strategy   • Dr. Nicole Stevens, Vice President of Clinical Research at Doterra, discusses the latest findings from Doterra's science team. • The team is working on multiple projects, including a new clinical trial. • DoTERRA's Essential Oil Research Priorities: • The team conducts pharmacokinetic studies to understand how essential oils are absorbed, distributed, metabolized, and eliminated in the body. • Safety markers, particularly liver and kidney function, are monitored during these studies. • The team also looks at efficacy markers to evaluate the benefits of the oils.   Adaptive Essential Oil Cognitive Study: • The team faced challenges in researching doTERRA products, including a frankincense study and the Adaptive essential oil blend. • The study was creatively designed to test the oil's effectiveness without alerting participants.   doTerra Supplements: Bioavailability and Benefits: • The team discusses the development and benefits of several doTerra supplements. • VMG, E Omega, and PB Restore are some of the supplements that have shown benefits. • On Guard Chewables Boost Immune System: • The team has done pilot studies on On Guard, showing increased white blood cells and increased interleukins. • DDR Prime's Efficacy in Spinal MS: • The team is working on understanding the scientific mechanisms behind DDR Prime's effectiveness through epigenetic studies.   Prioritizing Health Issues With Supplements: • The team emphasizes not overwhelming the body with too many supplements at once. • Doterra's approach of starting with foundational wellness products and then adding targeted solutions based on individual health needs and goals is emphasized.   Doterra's Research Investment and Education: • Doterra is investing significantly in research across multiple departments, including clinical research, essential oil research, and research and development.   Nicole's Beauty and Wellness Routine: • Nicole shares her beauty and wellness routine, emphasizing the importance of internal health for external beauty. • She recommends using frankincense as a beauty serum, adding it to the Essential Skincare System and Yarrow Pom oil.   Essential Oils Safety and Usage: • Dr. Stevens addresses concerns about internal use of essential oils, advising sparing use and monitoring for side effects.   Doterra's Clinical Research and Education: • Dr. Stevens encourages excitement about Doterra's clinical research on essential oils and encourages users to feel support in their families and businesses.   Connect with us: Aisha Harley- www.aishaharley.com / Instagram @aisha.essentialwellness  Ariana Harley - https://www.arianaharley.com/ Josie Schmidt- FB Personal Page: https://www.facebook.com/josie.h.schmidt Arin - https://msha.ke/jasmineandjuniper/ Contact Email: aishaharley@comcast.net Welcome to the Visionary Leaders Podcast Here you will gain the knowledge you need to bring essential oils, plant medicine, wisdom, supplementation, and functional medicine into your life. We have a weekly show: “Learn to Be the Healer in Your Home,” where we hear stories from our community on how they integrated essential oils, supplementation, and functional medicine into their lives as a pathway to healing.  

In this podcast, Dr. Valentin Fuster discusses a groundbreaking study from the Orbiter 2 trial, which explores how dobutamine stress echocardiography (DSE) can predict the efficacy of percutaneous coronary intervention (PCI) in relieving angina in patients with stable coronary artery disease. The study reveals that the degree of ischemia, as measured by DSE, is strongly correlated with improvement in symptoms, offering new insights into patient selection for PCI treatment.

The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques. Podcast links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis  Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for MG in the US Article links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States Disclosures can be found at Neurology.org.

From studies, a biology lesson and diet considerations for a better behaved, less stressed pup. Studies and scientific literature:Kirschoff, 2019. The gut microbiome correlates with conspecific aggression in a small population of rescued dogsTaniya, 2022. Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic RegulationSharon, 2019. Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in MiceAppleton 2018, Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Micehttps://www.zoetisus.com/content/pages/products/dogs/Apoquel-Resources/documents/apoquel_prescribing_information.pdfBerg, 2023. Natural vs. Synthetic Vitamins – Why It MattersSchmidt, 2018. The fecal microbiome and metabolome differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial diets Syngai, 2015. Probiotics - the versatile functional food ingredientsAcruff, 2022. A Review of Application Strategies and Efficacy of Probiotics in Pet FoodBakthavachalu, 2020. Food Color and Autism: A Meta-AnalysisMugford, 1987. The influence of nutrition on canine behaviourArdolino, Plant and Mushroom Benefits for Pets

Show SummaryOn today's episode, we're featuring a conversation with Marine Corps Veteran, Michael Hudson, Vice President for Insider Risk and Suicide Prevention for Clearforce, a risk analytics company that has developed the Resolve platform that is designed to address challenges associated with personal risk, including increased risk for suicide in the service member and veteran population. Provide FeedbackAs a dedicated member of the audience, we would like to hear from you about the show. Please take a few minutes to share your thoughts about the show in this short feedback survey. By doing so, you will be entered to receive a signed copy of one of our host's three books on military and veteran mental health. About Today's GuestColonel Michael Hudson, United States Marine Corps (Ret.), served 30 years as an Aviator, Commanded a Helicopter Squadron and a Marine Expeditionary Unit in support of combat and contingency operation in Africa, Central and Pacific Commands. Has intelligence and operational background, lead joint operational centers, safety, and risk professional designation. Restructured and lead USMC Sexual Assault Prevention Response program, working closely with behavioral health and suicide prevention to take USMC from worst to best program in DoD.  Retiring in 2014, he joined ClearForce as they formed.  Hudson holds a bachelor's Degree from San Jose State University in Aeronautics, Master's Degree from the Naval War College in National Security and Strategic Studies, Master's Degree from Troy State University in Management and is Global Counter Insider Threat Program (GCITP) credentialed.Links Mentioned in this Episode Clearforce Web siteRESOLVE Platform Web sitePsychArmor Resource of the WeekThis week's resource of the week is the PsychArmor course, Helping Others Hold On. Compared to the civilian population, suicide rates among the military and Veterans is very high. This series of lessons help to give tools and tips to recognize, understand, and combat suicidal feelings in Veterans. You can find the resource here:  https://learn.psycharmor.org/courses/helping-others-hold-on Episode Partner: This week's episode is brought to you by Humana, a leading health and well-being company that has joined forces with PsychArmor to develop campaigns and courses that support veterans and their families in achieving their best health. To learn more about how Humana honors and serves veterans visit healthequity.humana.com/veterans” Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.     Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) - NEJM 2.     Diabetes and Anemia – Diabetes Care 3.     Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials – Diabetes Care 4.     Cardiovascular and Kidney Outcomes and Mortality With Long- Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials – Diabetes Care 5.     Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes - NEJM   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Arthrosamid or stem cell therapy: which is better for knee osteoarthritis? There's no simple answer, but MSK Doctors can tell you a little more about each treatment in its guide. Read the full guide at https://mskdoctors.com/doctors/thula-chelvan/articles/arthrosamid-vs-stem-cell-therapy-for-knee-pain-effectiveness-side-effects-cost or call 03300010048 to learn more. MSK Doctors City: Sleaford Address: MSK House London Road Website: https://www.mskdoctors.com

Lauren Jatt is an infectious diseases fellow at the University of Washington. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.P. Jatt and Others. An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP — Essential or Irrelevant? N Engl J Med 2025;392:1561-1563.

The Filtered Fragments (OG Filtrate)Joel TopfJennie LinSwapnil HiremathSpecial Guest Brad Rovin GN God and second author from The Ohio StateKoyal Jain GN Specialist from UNCAlfred Kim Rheumatologist from Washington UniversityEditing bySimon Topf and Nayan AroraThe Kidney Connection written and performed by by Tim YauShow NotesJoel's monologue One of the most surprising facts of nephrology is that despite conventional wisdom that lupus nephritis is an antibody mediated disease, that over a decade ago, the LUNAR investigtors were unable to find a significant benefit when rituximab was added to conventional therapy. And this was after the equally negative phase 2 trial of rituximab, EXPLORER.In fact, despite this finding rituximab has been able to burough its way into treatment of many nephrologists and rheumatologists as well as the KDIGO guidelines where it is suggested for patients with persistent disease activity or inadequate response to initial standard-of-care therapy.This long conflict is now coming to an end. Obinutuzumab, a newer, better monoclonal antibody targeting the same CD20 that we grew to love with rituximab, but it has a number of advantages.One. It is humanized antibody rather than a chimeric mouse-human antibodyTwo. It's cytotoxicity is not complement dependent an particular advantage if you want to deploy it ina disease where hypocomplementemia is a disease characteristicThree, and most importantly, it causes stronger and deeper b-cell depletion than rituximab. Better B-cell depletion in the blood and tissue.And this brings us to tonight's topic, we had already seen the phase two results of obinutuzumab which, unlike EXPLORER, were positive, we will look at the phase three regency trial. This makes the third novel lupus nephritis drug in the last 4 years. We continue to remake glomerular nephritis.LUNAR: Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study PubmedEXPLORER: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial PubmedREGENCY: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis NEJM | NephJCNOBILITY: B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial Annals of Rheumatic DiseaseComparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program PubMed CentralClass 5 lupus nephritis is slow to respond Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study ACR Meeting abstractTubular SecretionsSwap: Young Adult novel I Must Betray You by Ruta Sepetys (Amazon)Koyal: Taekwondo (Wikipedia)Jennie: these unprecedented times Trump NYT: Administration Freezes $1 Billion for Cornell and $790 Million for Northwestern, Officials SayAl: Acquired PodcastBrad: The Feather Thief by Kirk Wallace Johnson (Amazon)Joel: Paradise on Hulu (Wikipedia)

Show SummaryOn today's episode, we're featuring a conversation about a new film, SHEEPDOG, with the actors Steven Grayhm and Matt Dallas.Together, they worked on the movie, which is a film that explores the physical and psychological repercussions of trauma with a focus on Posttraumatic Growth. Provide FeedbackAs a dedicated member of the audience, we would like to hear from you about the show. Please take a few minutes to share your thoughts about the show in this short feedback survey. By doing so, you will be entered to receive a signed copy of one of our host's three books on military and veteran mental health. About Today's GuestSteven Grayhm was born in London, Ontario Canada, to a Polish German mother and Canadian father whose family lineage descends from the Weskarini Algonquin First Nation people of La Petite Nation (Little Nation) from Western Quebec, Canada. A graduate of the Royal Academy of Dramatic Art in the UK, Steven was nominated for a Hollywood Film Award at the Hollywood Film Awards for his short film, Vodka, Winter and The Cry of Violin, for which he starred, wrote, directed and produced. The film, based on a true story about his Polish grandparents' perilous twilight plight to save their only son from a Nazi German POW camp during the last winter of WWII, was nominated at Raindance UK and was awarded 'Best International Short' at the New York International Film Festival.Steven received critical acclaim for his performance as Young Eddie in the film adaptation of Mitch Albom's best-selling novel, “The Five People You Meet In Heaven”, starring Academy Award Winner Jon Voight, Academy Award Nominee's Jeff Daniels and Ellen Burstyn and Emmy Winner Michael Imperioli. Steven also appeared as series lead Liam Cullen, in Netflix's post-apocalyptic drama “Between”, and Robert Zemeckis' big budget documentary-drama, “Medal of Honor”. Steven has performed on stage including multiple stints in the title role of “Hamlet”, and in the LA theater production of August Strindberg's “The Father”, directed by Academy Award Winner Estelle Parsons, and starring Academy Winner's Al Pacino, Dianne Wiest, and Jessica Chastain. Steven recently returned behind the camera to direct himself in the upcoming Veterans feature film SHEEPDOG, for which he also wrote and produced. The film is Executive Produced by Joe Newcomb (Dallas Buyers Club), and co-stars Academy Award Nominee Virginia Madsen, Emmy Nominee Vondie Curtis Hall, SAG Nominee Dominic Fusuma, Tony Nominee Lilli Cooper and Matt Dallas. The film will be released In Theaters in the Fall 2025.Matt Dallas has starred in several films, and has played the title character in the ABC Family television series Kyle XY for three seasons. Dallas also appeared in Camp Slaughter (2005), Living The Dream (2006), and Babysitter Wanted (2008). He has been a guest on the TV show Entourage. In 2005, Dallas starred with Mischa Barton in James Blunt's music video for Goodbye My Lover and in 2008 he starred in Katy Perry's music video for "Thinking of You".Dallas was cast in ABC's Eastwick, playing Roxie's (Rebecca Romijn) love interest. In 2009, it was announced that Dallas would be appearing in the movie Beauty and the Briefcase with Hilary Duff. Dallas was in an indie western film called The First Ride of Wyatt Earp as Bat Masterson, which was released on March 6, 2012.In 2012, Dallas starred as Max in the musical love story movie You, Me, & the Circus. He played the role of Bat Masterson in an action packed western movie Wyatt Earp's Revenge with Val Kilmer. He also starred as Lance Leigh in the Hallmark movie Naughty or Nice with Hilarie Burton.  Dallas played the role of Scott Orenhauser in the indie sci-fi thriller film Life Tracker. Dallas had a recurring role in ABC Family show Baby Daddy, where he played Riley's (Chelsea Kane) love interest.In 2014, Dallas starred in the horror comedy movie Ghost of Goodnight Lane. In 2015, Dallas starred as Jake in the web series Anne & Jake. The series was released on YouTube on November 11, 2015. In 2017, Dallas starred as Declan in the drama film Alaska is a Drag, written and directed by Shaz Bennett. He also starred as Frank Dean in the western film Painted Woman directed by James Cotten.In 2018, Dallas starred as pastor John in supernatural horror film Along Came the Devil. In 2019, Dallas played the role of Greg Carlyle in the Lifetime thriller film A Daughter's Plan to Kill alongside Claire Coffee. He also co-starred as Bobby Browning in the romantic comedy Nearly Married starring Cassi Thomson.Links Mentioned in this Episode SHEEPDOG the Movie Web SiteSHEEPDOG on InstagramSHEEPDOG on FacebookPsychArmor Resource of the WeekThis week's resource of the week is the PsychArmor course, Posttraumatic Growth After Loss. In this course, Dr. Shauna Springer represents the Tragedy Assistance Program for Survivors as she discusses how the TAPS Suicide Prevention Model's third phase, posttraumatic growth, has affected one particular survivor. You can find the resource here:  https://learn.psycharmor.org/courses/Posttraumatic-Growth-after-Loss Episode Partner: This week's episode is brought to you by Humana, a leading health and well-being company that has joined forces with PsychArmor to develop campaigns and courses that support veterans and their families in achieving their best health. To learn more about how Humana honors and serves veterans visit healthequity.humana.com/veterans” Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

In this episode of Casual Cattle Conversations, Shaye Wanner talks with Kelly Sanders and Taylor Garcia from Westway Feed Products to break down the real benefits of liquid feed in the beef industry. From improving cattle nutrition to supporting better ranch management, this conversation tackles everything from urea safety and cost savings to optimizing calf growth. If you're curious about feed safety, supplement strategies, and boosting profitability on your ranch, this episode is for you. Top Takeaways: Liquid feed enhances pasture utilization and cow health. Urea is safe and effective when used correctly. Calves over 500 lbs can benefit from liquid nutritional supplements. Liquid feed improves labor efficiency and can reduce feed costs. Ranchers should seek customized feed programs for best results. Timestamps: 00:00 – Introduction to Liquid Feed and Its Importance 02:57 – Understanding Urea in Liquid Feed 05:58 – The Safety and Efficacy of Urea 08:55 – Cost Benefits of Liquid Feed 11:57 – Nutritional Value and Composition of Urea 15:12 – Year-Round Liquid Feed Availability 18:12 – Impact on Calf Growth and Development 20:48 – Debunking Myths About Urea 24:05 – Liquid Feed Delivery and Accessibility 26:48 – Final Thoughts and Resources Connect with Westway Feed Products

In today's world, Longevity is more than just a buzzword — it's a movement. But with the rise of social media influencers and viral health trends, the line between science and pseudoscience is getting dangerously blurry. While awareness is growing, so is the spread of misinformation, often misleading the curious and misinforming the informed.That's why we're cutting through the noise. Join us as we break down the myths, trends, and truths about health and longevity with some of the most respected voices in the field: Dr. Marcus Ranney, Dr. Matt Kaeberlein, and Brian Kennedy. Together, we'll explore what really works, what's hype, and how to navigate this ever-evolving landscape with clarity and confidence.This episode is available on Spotify: https://tinyurl.com/2pr764jtApple: YouTube: https://youtu.be/T8ICc4U81bE_______________________________________Follow the panel here: Dr. Matt Kaeberlein: https://www.linkedin.com/in/mkaeberlein/ Dr. Marcus Ranney: https://www.linkedin.com/in/docmranney/Brian Kennedy: https://www.linkedin.com/in/brian-kennedy-69777318/Dilip Kumar: https://www.linkedin.com/in/dilipevs/_______________________________________Chapters00:00 Coming Up!01:06 Introduction to the Podcast01:27 Meet the Experts04:20 What is Longevity?07:29 The Noise in Longevity Conversations10:43 The Role of Influencers12:46 The Demand for Better Health Models14:05 Navigating Information and Misinformation21:05 The Importance of Data in Longevity36:00 The Debate on Biological Age41:13 Future of Longevity Research48:39 Key Biomarkers for Health Monitoring51:39 Democratizing Health Diagnostics54:09 Introduction to Rapamycin01:06:56 The Role of Supplements in Health01:08:51 Evaluating the Safety and Efficacy of Supplements01:13:35 Pharmaceuticals vs. Lifestyle Interventions01:16:13 The Impact of GLP-1 Agonists on Weight Loss01:19:45 Final Thoughts and Practical Health Advice

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Eli Lilly will start a lcinical trial for tirzepatide for people with type 1 diabetes, more details on Dexcom's 15 day G7 sensor, Ozepmic pill form tested, type 5 diabetes identified and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week.. Eli Lilly takes the first steps toward getting tirzepatide approved for people with type 1 diabetes. Tirzepatide is sold under the brand names Mounjaro for type 2 and Zepbound for obesity. The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or are overweight. Participation in the study will last about 49 weeks. Official Title A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight This is a big deal because, even though many people with type 1 are able to get a prescription for tirzepatide, it's not approved for T1D and so insurers won't usually cover it.   https://clinicaltrials.gov/study/NCT06914895 XX The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there's little information on the drugs' safety and effectiveness for the condition. The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can't make enough of their own. Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them in people with type 1.   For the study, which was published last month in the journal Diabetes, Obesity, and Metabolism, researchers at Johns Hopkins University reviewed the medical records of more than 200,000 people with type 1 diabetes from 2008 to 2023. They grouped the data in three-year periods, starting with October 2008 to September 2011 and ending with October 2020 to September 2023. GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications in 2008, and 33% did by 2023 – an 800% increase. But these are anecdotal reports and may not reflect instances in which people have side effects or complications like low blood sugar, which can be life-threatening. But Shin says what's really needed is information from randomized, double-blinded studies, in which participants are followed forward in time and given either a drug or a placebo. https://www.cnn.com/2025/04/09/health/glp-1-type-1-diabetes-study/index.html   XX Later this month the FDA will conduct a final meeting regarding a new, investigational compound (sotagliflozin) soda-GLIFF-a-zin that has been shown to Improve QoL and Reduce Long-term Complications for people with type 1 diabetes (T1D). The patient advocacy group Taking Control of Your Diabetes (TCOYD.org) is working to inform the T1D community about sotagliflozin - and to encourage people to sign a Change.org petition directed towards FDA.  Last fall, the FDA declined to approve sotagliflozin due to concerns about a potential increased risk of diabetic ketoacidosis (DKA), despite this being a condition that people with T1D on insulin face and manage daily. While TCOYD respects FDA's caution, the group stands by T1D patients and their physicians who, as a team, balance risks and benefits every day. https://tcoyd.org/petition/ XX Dexcom receives FDA approval for it's G7 with 15 day wear. We have an interview with Chief Operating Officer Jake Leach coming up on Tuesday – we talk about the planned roll out of this sensor, what else has changed, and the fine print in the press release – it says    “A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days.   https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System/default.aspx?utm_source=www.diabetech.info&utm_medium=referral&utm_campaign=dexcom-g7-15-day-sensor-gets-fda-cleared-but-will-it-actually-last-that-long   XX Glucotrack is joining something called  FORGETDIABETES bionic pancreas initiative, - this is an European Union project that aims to develop a long-term automated insulin delivery system for type 1 diabetes patients. Glucotrack's Continuous Blood Glucose Monitor (CBGM) will be integrated into the system to provide real-time glucose readings. The initiative's goal is to create a bionic invisible pancreas that eliminates the need for therapeutic actions and reduces psychological burden.   The architecture of BIP encompasses a ground-breaking, lifelong lasting implanted ip glucose nanosensor; a radically novel ip hormone delivery pump, with unique non-invasive hormone refill with a magnetic docking pill and non-invasive wireless battery recharge; an intelligent closed-loop hormone dosing algorithm, optimized for ip sensing and delivery, individualized, adaptive and equipped with advanced self-diagnostic algorithms.     Pump refilling through a weekly oral recyclable drug pill will free T1D subjects from the burden of pain and awkward daily measurement and treatment actions. Wireless power transfer and data transmission to cloud-based data management system round-up to a revolutionary treatment device for this incurable chronic disease. key feature of BIP is to be fully-implantable and life-long lasting thanks to novel biocompatible and immune-optimized coatings guaranteeing long-term safety and stability https://www.stocktitan.net/news/GCTK/glucotrack-to-participate-in-forgetdiabetes-a-prominent-european-cjjldjb0dq7h.html XX A newly recognised form of diabetes, called Type 5, was announced this week at the World Congress of Diabetes 2025. A global task force will investigate this less-understood condition, which differs from Type 1 and Type 2 diabetes. Type 5 diabetes affects people who are underweight, lack a family history of diabetes and do not show the typical symptoms of Type 1 or Type 2 diabetes. The condition was first observed in the 1960s and referred to as J-type diabetes, after being detected in Jamaica. It was classified by the World Health Organisation in 1985, but removed in 1998 due to lack of physiological evidence. At the time, experts believed it to be a misdiagnosed case of Type 1 or 2 diabetes. New research has since confirmed that Type 5 is different. https://economictimes.indiatimes.com/news/new-updates/a-new-type-of-diabetes-has-been-found-by-scientists-and-it-doesnt-show-the-typical-symptoms-of-type-1-or-type-2/articleshow/120276658.cms?from=mdr   XX Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. A new clinical trial, co-led by endocrinologist and diabetes specialist John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine, has demonstrated that the oral form of semaglutide significantly lowers the risk of cardiovascular events in individuals with type 2 diabetes, atherosclerotic cardiovascular disease, and/or chronic kidney disease. Results from the rather large, international trial were published in the New England Journal of Medicine and presented at the American College of Cardiology's Annual Scientific Session & Expo in Chicago, Illinois.     The effect of oral semaglutide on cardiovascular outcomes was consistent with other clinical trials involving injectable semaglutide, but more trials are needed to determine if one method may be more effective than the other at reducing major cardiovascular events. https://scitechdaily.com/new-pill-form-of-semaglutide-shows-major-benefits-for-people-with-diabetes/ XX April 14 (UPI) -- The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States. Novo Nordisk, the Danish-headquartered manufacturer, informed the FDA on April 3 that counterfeit 1-milligram injections of semaglutide were being distributed outside its authorized supply chain. The FDA and Novo Nordisk are testing the fake products to identify whether they're safe. Patients are asked to obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for any signs of counterfeiting. People in possession of the fake product are urged to call Novo Nordisk customer care at 800-727-6500 Monday through Friday from 8:30 a.m. to 6 p.m. EDT and report it to the FDA's criminal activity division's website. Side effects can be reported to FDA's MedWatch Safety Information and Adverse Event Reporting Program (800-FDA-1088 or www.fda.gov/medwatch) as well as to Novo Nordisk, at 800-727-6500. https://www.upi.com/Health_News/2025/04/14/FDA-fake-Ozempic-drugs-Novo-Nordisk/6841744666854/ XX Can a digital lifestyle modification program reduce diabetes risk? A new study shows that the lifestyle intervention significantly reduced 10-year diabetes risk among prediabetics by nearly 46% and increased the diabetes remission rate, highlighting the importance of lifestyle changes. However, the study was not a randomized trial, and participation in the lifestyle intervention was voluntary, which may introduce selection bias. The study evaluated 133,764 adults, categorizing them as diabetic (7.5%), prediabetic (36.2%), and healthy (56.3%), based on fasting glucose and HbA1c levels. https://www.news-medical.net/news/20250414/Digital-lifestyle-program-cuts-diabetes-risk-by-4625-in-prediabetics-study-of-130k2b-adults-reveals.aspx XX Chrissy Teigan is speaking out about her son's type 1 diagnosis – teaming up with Sanofi to encourage people to screen early for Type 1 diabetes.   Teigen got a crash course in the risks of undiagnosed Type 1 diabetes when her 6-year-old son, Miles, was hospitalized with complications of the autoimmune disease last year. The family knew nothing about Type 1 diabetes when Miles was diagnosed during an unexpected medical emergency, Teigen said in a Tuesday announcement. “We were confused and scared when Miles was first diagnosed,” she said in a statement. “There is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!”   Teigen shared her family's story in a two-minute video on ScreenForType1.com, a Sanofi website that discusses how to get screened for the condition. Miles' diagnosis made Teigen feel like she “went from a mom to a doctor overnight,” she said. That experience is why Teigen said she is “begging you: Do this one thing, and screen yourself and your family for Type 1 diabetes.” https://www.fiercepharma.com/marketing/sanofi-signs-chrissy-teigen-diabetes-screening-campaign XX Dr. Richard Bernstein – best known for his advocacy around low carb diets for people with diabetes – died this week at the age of 90. Born in 1934 in Brooklyn, New York, he was diagnosed with type 1 at age 12. In the 1970s he adapted a blood glucose monitor for home use and helped pioneer home glucose monitoring. He published multiple books on Diabetes including the #1 selling Diabetes book on Amazon.Com “Dr. Bernstein's Diabetes Solution: A Complete Guide to Achieving Normal Blood Sugars” and “Diabetes Type II: Living a Long, Healthy Life Through Blood Sugar Normalization”.  He practiced and saw patients right up until his death.

In this conversation, Dr. Riley Kirk and Dr. Josh Kaplan delve into the complexities of cannabis research, particularly focusing on CBD and its therapeutic potential for conditions like epilepsy. Dr. Kaplan shares his journey into cannabis research, highlighting the significance of understanding CBD's mechanisms, the role of GPR55 in seizure management, and the challenges of dosing CBD effectively. They also discuss the entourage effect, the importance of personalized medicine, and the ongoing research into terpenes and their interactions with cannabinoids. The conversation emphasizes the need for further exploration in cannabis research to develop safe and effective therapies, especially for vulnerable populations like children. In this conversation, Josh Kaplan discusses the therapeutic potential of CBD, particularly in relation to traumatic brain injuries and neurodegenerative diseases. He emphasizes the safety of CBD compared to THC and explores its role in preventative treatments. The conversation also delves into ongoing clinical trials, particularly within the NFL, and the challenges faced in cannabis research, including dosing and the variability of individual responses to cannabinoids. Kaplan highlights the importance of understanding the entourage effect and the need for more personalized approaches in cannabis treatment. More about Dr. Kaplan: Dr. Kaplan is an Associate Professor in the Behavioral Neuroscience Program. His expertise is in neurophysiology, neuropharmacology, and animal behavior techniques, which his lab uses to study the therapeutic benefits and developmental consequences of cannabis in pre-clinical rodent models. His research seeks to optimize cannabinoid and terpene compositions to maximize benefit and minimize adverse consequences.  Dr. Kaplan has a strong passion for teaching and communicating science. His scientific writing specializes in the science of cannabis and its medicinal utility. He was included in High Times' 100 Most Influential People in Cannabis (2018) and Cannabis Newsletter's Top 100 (2021). Follow Dr.Kaplan's research: https://wp.wwu.edu/kaplanlab/ Preorder my book Reefer Wellness! https://www.amazon.com/Reefer-Wellness-Understanding-Cannabis-Medicine/dp/0593847156 Seed Giveaway Thank you to Royal Queen Seeds and Last Green Valley Seeds for donating to this week's giveaway! To enter, fill out the form below, winners will be selected at random.  https://forms.gle/1vWtsBMGaux9x5Mf6 ✨ Want Exclusive Content? Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one. www.Patreon.com/Cannabichem

Show SummaryOn today's episode, we're featuring a conversation with Dr. Melita “Chepa” Rank, a member of the Húŋkpati Dakota Tribe and a dedicated social worker whose mission centers around holistic wellness and well-being within Tribal and Indigenous communities.Provide FeedbackAs a dedicated member of the audience, we would like to hear from you about the show. Please take a few minutes to share your thoughts about the show in this short feedback survey. By doing so, you will be entered to receive a signed copy of one of our host's three books on military and veteran mental health. About Today's GuestDr. Melita “Chepa” Rank, a member of the Hunkpati Dakota Tribe, is a dedicated social worker whose mission centers around holistic wellness and well-being within Tribal and Indigenous communities. Her work is driven by innovative practices aimed at tackling the significant challenges faced by our Tribal communities knowing our people are a vital resource and asset.  Dr. Rank's impactful work includes integrated systems for wellness with the emphasize on cultural strengths as a pathway to wellness and well-being knowing our cultural traditions, customs, beliefs, and practices are the foundation to well-being and wellness. Dr. Rank champions the belief-as relatives we are the primary responders who are critical in providing the help where needed and lead the way in centering our well-being.    Recognizing the alarming rates of suicide in Indigenous nations, Dr. Rank works tirelessly on suicide prevention initiatives. Her efforts aim to provide support, resources, and hope.  Within Tribal nations, Dr. Rank advocates for services centered in physical, mental, and spiritual well-being that fosters a culture of overall wellness. A cornerstone value she holds at the forefront is utilizing a collective impact approach to improve health and utilization of data for programmatic decision-making.Dr. Rank journey in early foundational learning began in Head Start, an experience she proudly carries forward as a testament to the importance of early childhood education.  Her academic pathway includes: Doctor of Social Work -University of Southern California Master of Social Work -Florida State UniversityBachelor of Social Work-University of KansasAssociate of Arts-Haskell Indian Junior College As a dedicated professional, Dr. Rank serves as a National Trainer and is a certified trainer in Adverse Childhood Experiences along with various other prevention-based programs. She resides on the Hunkpati Nation, where she finds joy in raising her family, cherishing time spent with her grandchildren and family amid the beauty of her Tribal Nation.    Links Mentioned in this Episode Húŋkpati Oyáte Web SitePsychArmor Resource of the WeekThis week's resource of the week is a previous conversation about Native and Tribal veterans on the Behind the Mission podcast, episode 141 with Dean Dauphinais. Dean is a Marine Corps Veteran and Veteran, as well as an enrolled member of the Turtle Mountain Band of Chippewa Indians, and is focused on supporting his fellow Native and Tribal veterans.  You can find the resource here:  https://psycharmor.org/podcast/dean-dauphinais Episode Partner: This week's episode is brought to you by Humana, a leading health and well-being company that has joined forces with PsychArmor to develop campaigns and courses that support veterans and their families in achieving their best health. To learn more about how Humana honors and serves veterans visit healthequity.humana.com/veterans” Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

In this episode of Quah (Q & A), Sal, Adam & Justin coach four Pump Heads via Zoom. Mind Pump Fit Tip: Build a big round butt in 30 days by following these 6 steps. (1:48) Creatine and depression. (24:19) Sal's weekly training update. (27:13) Justin's Road to 315. (30:31) The meaningful lessons sports provide. (37:30) Music's effect on athletic performance. (42:57) Mind Pump's current music playlist. (48:39) An update on Callum Ferris. (53:45) #ListenerLive question #1 – My typical meal consists of just protein and vegetables—usually steak or chicken with broccoli and grilled onions. In this case, how crucial is it to prioritize eating protein before vegetables? (55:15) #ListenerLive question #2 – What is the significance of 3 sets vs 2? Would it be better to cut the weight down vs cutting a set? (1:06:44) #ListenerLive question #3 – How often should I be changing my programming?  When do I know I should be changing my programming? (1:12:13) #ListenerLive question #4 – Do you guys have any advice on how to best manage the excess skin affecting my body, or ways to adapt in the gym as the skin movement sometimes causes imbalances during movement and lifts? (1:18:27) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Organifi for the exclusive offer for Mind Pump listeners! **Promo code MINDPUMP at checkout for 20% off. (4/12 - 4/13: National Garden Weekend. Free Green Juice & fun-sized Happy Drops w/any order of 3.) ** Visit Brain.fm for an exclusive offer for Mind Pump listeners. ** Get 30 days of free access to science-backed music. ** April Special: MAPS HIIT or Extreme Fitness Bundle 50% off! ** Code APRIL50 at checkout ** The effect of acute sleep deprivation on skeletal muscle protein synthesis and the hormonal environment Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area Justin's Road to 315 Push Press High-Tempo Music Can Enhance Performance During Exercise, Study Suggests Visit Seed for an exclusive offer for Mind Pump listeners! **Promo code 25MINDPUMP at checkout for 25% off your first month's supply of Seed's DS-01® Daily Synbiotic** Mind Pump # 2385: Five Reasons Why You Should Hire a Trainer Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Jordan Shallow D.C (@the_muscle_doc) Instagram Stan “Rhino” Efferding (@stanefferding) Instagram SJ&Ferris (@sjandferris) Instagram Jen Cohen (@therealjencohen) Instagram  

Network security has evolved from stateful perimeter firewalls with maybe some IDS/IPS to a complex stack delivered as numerous unique tools, which often don’t talk to one another and may need to be operated by specialists. In this environment it’s hard to unify a security policy, troubleshoot problems, manage and operate tools, and respond effectively... Read more »

Network security has evolved from stateful perimeter firewalls with maybe some IDS/IPS to a complex stack delivered as numerous unique tools, which often don’t talk to one another and may need to be operated by specialists. In this environment it’s hard to unify a security policy, troubleshoot problems, manage and operate tools, and respond effectively... Read more »

Network security has evolved from stateful perimeter firewalls with maybe some IDS/IPS to a complex stack delivered as numerous unique tools, which often don’t talk to one another and may need to be operated by specialists. In this environment it’s hard to unify a security policy, troubleshoot problems, manage and operate tools, and respond effectively... Read more »

In this episode of the Meatspad Podcast, we're joined by Dr. Wes Schilling, Professor of Meat Science, Sensory Science, and Food Chemistry at Mississippi State University. With years of industry experience and a hands-on teaching approach. We dive into the use of phosphates in meat products, what they do, their limitations, and why they're essential for improving product quality. Don't miss this episode packed with practical science and real-world applications!

Show SummaryOn today's episode, we're featuring a conversation with Denise Meine-Graham. Denise and her husband help communities develop Local Outreach to Suicide Survivor teams, or LOSS Teams, to provide support to others bereaved by suicide. Provide FeedbackAs a dedicated member of the audience, we would like to hear from you about the show. Please take a few minutes to share your thoughts about the show in this short feedback survey. By doing so, you will be entered to receive a signed copy of one of our host's three books on military and veteran mental health. About Today's GuestDenise Meine-Graham, a former corporate executive, turned her personal tragedy into a mission of hope after losing her son, Drey, to suicide in 2012. She founded LOSS Community Services in Columbus, Ohio, to provide support and healing to those bereaved by suicide. In 2022, she transitioned to the role of Director Emerita.That same year, Denise and her husband, Robbie, established Postvention Consulting LLC to help communities develop LOSS Teams and postvention programs nationwide. They also work at the state level to build postvention infrastructures and networks. In 2023, Postvention Consulting took on the responsibility—originally led by Dr. Frank Campbell—of expanding the LOSS Team active postvention model. LOSSteam.comWith a strong business background, Denise has developed a structured approach to launching LOSS Teams, contributed to nationally recognized media guidelines on suicide reporting, testified before state legislators on postvention-related policies, and frequently speaks on suicide postvention and her journey as a loss survivor.Denise has received multiple awards recognizing her achievements and collaborative leadership. She has extensive training in suicide prevention and has served as a QPR (Question, Persuade, Refer) Instructor, CALM (Counseling on Access to Lethal Means) trainer, and “How to Share Your Story” trainer. She is a Certified Thanatologist, a Certified Psychological Autopsy Investigator, and holds a Death and Grief Studies certification from the Center for Loss and Life Transition.Links Mentioned in this Episode Loss Team WebsitePsychArmor Resource of the WeekThis week's resource of the week is the PsychArmor course, Postvention: Healing After Suicide. Postvention is a term unfamiliar to many people, yet it is a critical component of suicide prevention. This course explains postvention, what it is and why it is important. You can find the resource here:  https://learn.psycharmor.org/courses/postvention-healing-after-suicide Episode Partner: This week's episode is brought to you by Humana, a leading health and well-being company that has joined forces with PsychArmor to develop campaigns and courses that support veterans and their families in achieving their best health. To learn more about how Humana honors and serves veterans visit healthequity.humana.com/veterans” Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid's research involves the IER3 gene, which is an important modulator of the body's inflammatory response via its action in major immune cells, including macrophages and T-cells, and plays a role in metabolic disorders such as obesity, diabetes, and atherosclerosis, revealing a previously unknown function of this protein. Key Concepts Drug development is a multi-decade journey – human clinical trials occur very late in the process. Drug development often starts before a drug molecule is even conceived by identifying potential drug targets. Chronic inflammation is important for a variety of diseases, including obesity and atherosclerosis. Dr. Shahid's work focuses on a specific gene, Immediate Early Response 3 Gene (IER3 or IEX-1), and its role in modulating the inflammatory response in these disease states. The research process frequently leads to unexpected discoveries and new lines of inquiry. With Dr. Shahid, his work in obesity and inflammation actually led to a new understanding of the IER3's role in the interplay between macrophages, inflammation, and energy expenditure. References Shahid M, Javed AA, Chandra D, et al. IER3 deficiency induces browning of white adipose tissue and resists diet-induced obesity. Sci Rep. 2016;6:24135. Published 2016 Apr 11. doi:10.1038/srep24135 Shahid M, Hermes EL, Chandra D, et al. J Am Heart Assoc. 2018;7:e009261. DOI: 10.1161/JAHA.118.009261. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646 Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497-2505. doi:10.1056/NEJMoa1912388

Take a sneak peek at this month's Fertility & Sterility! Articles discussed this month are:   01:47 Puberty progression in girls with Turner syndrome after ovarian tissue cryopreservation 14:55 Optimal Restoration of Spermatogenesis following Testosterone Therapy using hCG and FSH 27:58 Human embryos with segmental aneuploidies display delayed early development: a multi-centre morphokinetic analysis 39:56 Neurodevelopmental or behavioural disorders in children conceived after assisted reproductive technologies: A nationwide cohort study 45:23 Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study 51:13 Ovulation trigger versus spontaneous LH surge on live birth rate following frozen embryo transfer in a natural cycle: a randomized controlled trial 60:29 A Cost Analysis of Clomiphene Citrate, Letrozole and Gonadotropin with Intrauterine Insemination using Outcome Data from the AMIGOS Trial   View Fertility and Sterility at https://www.fertstert.org/

In this episode of Normal Christian Life, we talk about the significance of silence, especially during the season of Lent. Reflecting on Jesus' 40 days in the desert and the importance of stillness, this discussion reveals how silence can enhance our spiritual lives, cultivate holiness, and foster a deeper connection with God. Joined by insightful quotes from saints and personal testimonies, this episode offers practical steps for incorporating silence into our daily lives, ensuring that even in a noisy world, we can find moments of divine encounter and peace.   00:00 Introduction to Silence and Lent 00:24 Jesus' 40 Days in the Desert 01:14 Addiction to Noise 02:11 Cultural Challenges and Silence 06:51 Historical Perspectives on Silence 15:51 Personal Experiences with Silence 23:52 The Importance of Silence in Prayer 25:42 Encountering God in Silence 37:58 The Gift of Receiving in Prayer 38:11 The Samaritan Woman and Living Water 38:34 The Challenge of Active Prayer 38:53 The Role of Passivity in Prayer 39:32 Faith and the Efficacy of Prayer 41:13 The Importance of Silence in Prayer 43:33 Quotes on Silence and Prayer 45:32 Personal Experiences with Silent Retreats 48:34 The Role of Silence in Cultivating Holiness 56:42 Practical Tips for Cultivating Silence 01:04:31 The Impact of Silence on Daily Life 01:12:33 Concluding Thoughts and Prayer

In this episode of the Rachel Hollis podcast, Rachel explores the science of happiness alongside bestselling author Gretchen Rubin, Harvard professor Arthur Brooks, holistic health pioneer Dr. Andrew Weil, and intimacy expert Dr. Emily Morse. The discussion delves into how our habits, physical wellbeing, and relationships contribute to our overall happiness.Get your copy of Rachel's New Book Here: Audible, Amazon, Barnes & Noble, Books-A-Millon, Bookshop.org, or wherever books are sold!Featured Episodes Gretchen Rubin | 350Arthur Brooks | 561Dr. Andrew Weil | 658Dr. Emily Morse | 62702:21 Exploring the Science of Happiness03:26 Gretchen Rubin's Happiness Project08:05 The Four Tendencies Framework14:44 Arthur Brooks on Genetic Influence and Happiness19:46 Pleasure, People, and Memory: The Formula for Happiness21:44 Understanding Neuromodulators and Pleasure21:58 The Neuroscience of Diet and Social Eating00:00 Mental Nutrition and Lifestyle Interventions24:35 The Safety and Efficacy of Natural Remedies26:52 The Misuse of Pharmaceutical Drugs27:23 Integrative Medicine and Lifestyle Changes33:32 Exploring Sexual Relationships and Intimacy37:34 The Importance of Pleasure and Intimacy38:49 Communicating About Sex and Body Confidence41:10 Final Thoughts on Sexual Health and RelationshipsSign up for Rachel's weekly email: https://msrachelhollis.com/insider/Call the podcast hotline and leave a voicemail! Call (737) 400-4626Watch the podcast on YouTube: https://www.youtube.com/c/RachelHollisMotivation/videosFollow along on Instagram: https://www.instagram.com/MsRachelHollis To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices. 

In this episode, Patrick and Emma start with diving into the impact of AMC Audiences for Sponsored Ads and what Flywheel has built to maximize precision and efficiency with this extended capability. Next, they cover a recent article on JBPs that's all about RMN efficacy and how brands and retailers need to solve issues in order for JBPs to reach their potential. Last up, how to make sure advertiser's dollars are reaching human eyes vs. bots through closed-loop, deterministic measurement.

Chapters 00:00 Introduction to Tendinopathy and Personal Journey 02:46 Understanding Tendinopathy: Inflammation vs. Degeneration 06:02 The Role of Isometrics in Tendon Rehabilitation 09:10 Muscle Function vs. Tendon Focus in Rehabilitation 11:50 Managing Load: Balancing Pain and Progress 15:07 Powerlifting and Tendinopathy: A Unique Perspective 17:54 Biomechanics and Chronic Workload in Tendon Pain 32:51 Understanding Tendon Biomechanics 34:10 Mismanagement of Tendon Injuries 37:24 The Importance of Progressive Loading 39:07 Transitioning to Remote Rehabilitation 41:03 The Role of Imaging in Tendon Injuries 44:27 Navigating Partial Tears and Surgical Decisions 47:41 Post-Surgery Rehabilitation Challenges 53:27 The Efficacy of Injections in Tendon Pain 56:54 The Debate on Stretching Tendons 01:00:00 Exploring BPC-157 and Its Anecdotal Use   Takeaways Tendinopathy is often mismanaged in clinical settings. Isometrics can be beneficial but are not a one-size-fits-all solution. Muscle function and nervous system adaptation are crucial in rehab. Pain should guide rehabilitation strategies. Heavy loads must be relative to the individual's condition. Powerlifters can experience patellar tendinopathy due to high volume and intensity. Biomechanics play a role in tendon injuries but are not the sole factor. Chronic workload changes can lead to tendon pain. Expectations and beliefs can influence treatment outcomes. Individualized approaches are essential for effective rehabilitation. High bar back squats may aggravate tendon injuries more than low bar squats. Mismanagement of tendon injuries often leads to prolonged recovery times. Progressive loading is crucial for effective rehabilitation. Remote rehabilitation can provide more frequent and tailored care. Imaging can create fear and confusion about tendon injuries. Partial tears may not always require surgical intervention. Post-surgery rehabilitation is highly individualized and can be challenging. Injections may provide temporary relief but are not a guaranteed solution. Stretching tendons should be minimized, especially in early stages of rehab. BPC-157's effectiveness remains largely anecdotal and requires more research.   Alex's links: https://stan.store/training_with_tendinopathy Alex's Instagram: https://www.instagram.com/training_with_tendinopathy/ Notes: https://jackedathlete.com/podcast-137-tendons-with-alex-nelson/

In today's episode, we are happy to hear from our clinic's Dr. Scott and one of his patients, Keith about his successful experience tackling gut health issues. Keith's case posed a very common conundrum that we've seen in many with gut health issues - are we dealing with bacterial overgrowth (SIBO), fungal overgrowth (candida) or potentially both? We'll walk through some of the key indications that Keith's initial SIBO diagnosis was actually a candida case, and we'll cover the best testing and treatments that led to Keith's recovery.  Need help navigating your digestive or other health conditions? Learn more about our virtual clinic: https://drruscio.com/virtual-clinic/

Mind Pump Fit Tip: Stop your full-body or split routine now! It might be killing your gains! (2:14) Do you want to eat more, bump your calories, and protein? Eat grass-fed! (22:57) Brain cancer and diet. (26:07) Sal's beefy. (33:33) The impact of group coaching. (36:28) “You got really nice skin bro.” (40:24) The age of the AI influencer. (42:21) The Christianity explosion. (49:49) #ListenerLive question #1 – Do you have any information about the impact of weightlifting/resistance training on liver function tests? (54:38) #ListenerLive question #2 – What foods would you recommend eating during a bulk to avoid digestive discomfort? Do you have any advice for improving grip strength or preventing this discomfort? (1:02:15) #ListenerLive question #3 – Have you guys had any clients with hyper-mobility issues, and can you offer any insight on dos and don'ts on how to train/help someone stay safe and still get strong with this issue? (1:16:30) #ListenerLive question #4 – How can I hack my mindset? (1:26:40) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Butcher Box for this month's exclusive Mind Pump offer!  ** New users will receive their choice between chicken breast, ground beef, or top sirloin in every box for a year + use code MINDPUMP and get $20 off your first box. ** Visit Caldera Lab for an exclusive offer for Mind Pump listeners! **Code MINDPUMP20 for 20% off your first order of their best products. ** MAPS Transform Special Launch! ** Code TRANSFORM70 at checkout. $70 Off Gym + At Home workouts. Includes: Adam's 90-Day Body Recomp Journal, and the MAPS Transformation Diet Guide. ** Efficacy of Split Versus Full-Body Resistance Training on Strength and Muscle Growth: A Systematic Review With Meta-Analysis Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study Mind Pump #1030: Dr. Roy Vongtama The SIMPLE STEPS To Burn Fat, Build Muscle & Speed Up Your Metabolism - Sal Di Stefano Mind Pump # 2545: Transform Your Body in 90 Days Watch Apple Cider Vinegar | Netflix Official Site Seeking God, or Peter Thiel, in Silicon Valley – DNyuz Visit MASSZYMES by biOptimizers for an exclusive offer for Mind Pump listeners! **Promo code MINDPUMP10 at checkout** Train the Trainer Webinar Series Mind Pump # 1895: Eight Hacks for an Insanely Strong Grip How to Undulate Your Calories for Faster Weight Loss & an Improved Metabolism The Dunphy Squat | At Home Squat Variation – YouTube Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Roy Vongtama MD (@doctorroyv) Instagram Adam | Relationship Psychology (@attachmentadam) Instagram Justin Brink DC (@dr.justinbrink) Instagram